← back to search

Yackov Berkun

Hebrew University of Jerusalem · IL
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Medicine, Pediatrics, Familial Mediterranean fever, Adenosine deaminase, Vasculitis, and Internal medicine.
h-index
citations
2,117
works
25
NIH funding
primary concept
email

Recent publications

A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
The Journal of Experimental Medicine 2024cited by 13position: middledoi
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Annals of the Rheumatic Diseases 2023cited by 398position: middledoi
Evaluation and Management of Deficiency of Adenosine Deaminase 2
JAMA Network Open 2023cited by 79position: middledoi
Pediatric respiratory admissions and related viral infections during the COVID‐19 pandemic
Pediatric Pulmonology 2023cited by 11position: middledoi
Platelet count and risk of severe illness in hospitalised children with <scp>Influenza‐Like</scp> illness
Acta Paediatrica 2023cited by 3position: middledoi
Tofacitinib-induced progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome
Neurological Sciences 2023cited by 3position: middledoi
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases
Annals of the Rheumatic Diseases 2022cited by 29position: middledoi
Six cases of pityriasis rosea following SARS‐CoV‐2 vaccination with BNT162b2
JDDG Journal der Deutschen Dermatologischen Gesellschaft 2022cited by 8position: middledoi
Risk factors for haemodynamic compromise in multisystem inflammatory syndrome in children: a multicentre retrospective study
Lara D. Veeken 2022cited by 6position: middledoi
Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis: A Nationwide Israeli Retrospective Study
The Journal of Rheumatology 2022cited by 5position: middledoi
Multisystem inflammatory syndrome in children associated with COVID‐19 presenting as cervical inflammation
Acta Paediatrica 2022cited by 4position: lastdoi
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
Frontiers in Immunology 2021cited by 99position: middledoi
Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings
European Journal of Pediatrics 2021cited by 9position: lastdoi
Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever
The Journal of Rheumatology 2021cited by 7position: lastdoi
Increased prevalence of attention-deficit hyperactivity disorder symptomatology in patients with familial Mediterranean fever
Modern Rheumatology 2021cited by 5position: lastdoi
POS1183 OUTCOMES OF COVID-19 INFECTION AMONG CHILDREN AND YOUNG PEOPLE WITH PRE-EXISTING RHEUMATIC AND MUSCULOSKELETAL DISEASES
Annals of the Rheumatic Diseases 2021cited by 2position: middledoi
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Journal of Clinical Investigation 2018cited by 513position: middledoi
Adenosine Deaminase 2 Deficiency: More Than Monogenic Vasculitis.
PubMed 2017cited by 7position: first
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency
The Journal of Pediatrics 2016cited by 111position: middledoi
Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication
European Journal of Pediatrics 2015cited by 26position: middledoi
Seasonality of birth of patients with juvenile idiopathic arthritis.
PubMed 2015cited by 17position: first
Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
New England Journal of Medicine 2014cited by 696position: middledoi
Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis
Immunologic Research 2013cited by 20position: lastdoi
NOD2/CARD15 Gene Mutations in Patients with Familial Mediterranean Fever
Seminars in Arthritis and Rheumatism 2012cited by 23position: firstdoi
Pharmacokinetics and Colchicine in Pediatric and Adult Patients with Familial Mediterranean Fever
International Journal of Immunopathology and Pharmacology 2012cited by 23position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Isaiah D. Wexler · Hadassah Medical Center3 papers (2015–2021) · 3 papers (2012–2015)Eli M. Eisenstein · Edmond and Lily Safra Children's Hospital3 papers (2021–2022) · 3 papers (2021–2022) · 3 papers (2021–2022)Yosef Uziel · Amgen (United States)3 papers (2021–2022)Ruth Costello · London School of Hygiene & Tropical Medicine2 papers (2021–2022)Daniel Clemente · Hospital Infantil Universitario Niño Jesús2 papers (2021–2022)Lianne Kearsley‐Fleet · University of London2 papers (2021–2022) · 2 papers (2022–2022)Nico Wulffraat · ERN GUARD-Heart2 papers (2021–2022) · 2 papers (2021–2022)Rebecca Brooks · Southwestern Medical Center2 papers (2022–2023)Elsa F Mateus · Amgen (United States)2 papers (2021–2022)Pedro Machado · Fermi National Accelerator Laboratory2 papers (2021–2022)Eran Lavi · Hebrew University of Jerusalem2 papers (2015–2021) · 2 papers (2012–2012) · 2 papers (2022–2022)Liora Harel · Nationwide Children's Hospital2 papers (2022–2022)Florence A. Aeschlimann · Hospital for Sick Children2 papers (2021–2022)